DESTINY-Breast03 Phase 3 Study Results

ASCO/ESMO BC Presentation Materials Dato-DXd Initial results of BEGONIA study - Schmid P et al., ESMO BC 2022 #166 Mini Oral HER3-DXd Results from Ph1/2 study in patients with HER3 expressing mBC - Krop I et al., ASCO 2022 #1002 Oral Results from Ph1 dose expansion study in patients with NSCLC without EGFR activating mutations - Steuer C et al., ASCO 2022 #9017 Poster DS-6000 Initial results from Ph1 study – Hamilton E et al., ASCO 2022 #3002 Oral DS-6157 Results from Ph1 study - George S et al., ASCO 2022 #11512 Poster Daiichi-Sankyo 2

View entire presentation